Amylin (AMLN) Issues Detailed Statement Regarding FDA Alert on BYETTA - Shares Down Almost 9% in After-Hours
Tweet Send to a Friend
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly (NYSE: LLY) in a conference call today provided context and additional information ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
